187 related articles for article (PubMed ID: 17852716)
1. Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy.
Schilling A; Seibold M; Mansmann V; Gleissner B
Med Mycol; 2008 Feb; 46(1):79-83. PubMed ID: 17852716
[TBL] [Abstract][Full Text] [Related]
2. Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
Pemán J; Jarque I; Bosch M; Cantón E; Salavert M; de Llanos R; Molina A
J Clin Microbiol; 2006 May; 44(5):1912-4. PubMed ID: 16672439
[TBL] [Abstract][Full Text] [Related]
3. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Gahn B; Schub N; Repp R; Gramatzki M
Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
[TBL] [Abstract][Full Text] [Related]
4. Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.
Conen A; Weisser M; Jörg CO; Battegay M; Trampuz A; Frei R; Christen S; Heim D; Gratwohl A; Flückiger U
Transpl Infect Dis; 2008 Feb; 10(1):66-70. PubMed ID: 17511816
[TBL] [Abstract][Full Text] [Related]
5. Candida glabrata vertebral osteomyelitis in an immunosuppressed patient.
Tan AC; Parker N; Arnold M
Int J Rheum Dis; 2014 Feb; 17(2):229-31. PubMed ID: 24576284
[No Abstract] [Full Text] [Related]
6. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
López-Ciudad V; Castro-Orjales MJ; León C; Sanz-Rodríguez C; de la Torre-Fernández MJ; Pérez de Juan-Romero MA; Collell-Llach MD; Díaz-López MD
BMC Infect Dis; 2006 Apr; 6():73. PubMed ID: 16608509
[TBL] [Abstract][Full Text] [Related]
7. Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature.
Pelletier R; Alarie I; Lagacé R; Walsh TJ
Med Mycol; 2005 Sep; 43(6):559-64. PubMed ID: 16320498
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
9. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
Shorr AF; Wu C; Kothari S
J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Fanci R
J Chemother; 2009 Feb; 21(1):105-7. PubMed ID: 19297283
[No Abstract] [Full Text] [Related]
11. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Pan SC; Hsieh SM; Chang SC; Lee HT; Chen YC
Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.
Olver WJ; Scott F; Shankland GS
Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561
[TBL] [Abstract][Full Text] [Related]
13. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
14. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Manfredi R; Sabbatani S
Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin therapy of neonates with invasive candidiasis.
Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
[TBL] [Abstract][Full Text] [Related]
16. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
McGee WT; Tereso GJ
Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of Candida parapsilosis (fluconazole-resistant) osteomyelitis with caspofungin in a HIV patient.
Legout L; Assal M; Rohner P; Lew D; Bernard L; Hoffmeyer P
Scand J Infect Dis; 2006; 38(8):728-30. PubMed ID: 16857628
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin for the treatment of less common forms of invasive candidiasis.
Cornely OA; Lasso M; Betts R; Klimko N; Vazquez J; Dobb G; Velez J; Williams-Diaz A; Lipka J; Taylor A; Sable C; Kartsonis N
J Antimicrob Chemother; 2007 Aug; 60(2):363-9. PubMed ID: 17526917
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
